amikacin has been researched along with zithromax in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.70) | 18.7374 |
1990's | 6 (16.22) | 18.2507 |
2000's | 11 (29.73) | 29.6817 |
2010's | 10 (27.03) | 24.3611 |
2020's | 9 (24.32) | 2.80 |
Authors | Studies |
---|---|
Fulcher, LC; Griffith, ME; Hawley, JS; Hospenthal, DR; Jorgensen, JH; McElmeel, ML; Murray, CK | 1 |
Hawley, JS; Jorgensen, JH; Murray, CK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bojkovic, J; Dean, CR; Dobler, M; Dzink-Fox, J; Glick, M; Hamann, LG; Kerrigan, J; Lanieri, L; Lenoir, F; Lilly, MD; Liu, E; Lu, Y; McKenney, D; Nunez, J; Osborne, C; Parker, DT; Patnaik, A; Peng, Y; Piizzi, G; Ranjitkar, S; Sprague, ER; Tommasi, R; Wang, B; Wang, H; Wattanasin, S; Xie, L; Yang, X; Yu, D | 1 |
Armstrong, D; Brown, IN; Brown, S; Dale, JW; Edwards, FF; Felder, MS; Ollar, RA | 1 |
Bermudez, LE; Young, LS | 1 |
Bermudez, LE; Kolonoski, P; Martinelli, J; Petrofsky, M; Young, LS | 1 |
Barbarini, D; Bono, L; Carretto, E; Marone, P; Telecco, S | 1 |
Muszynski, MJ; Rajyaguru, JM | 1 |
Durand, ML; Foster, CS; Nguyen, QD; Paton, B; Uy, HS | 1 |
Dart, JK; Horgan, SE; Matheson, MM; McLOUGHLIN-Borlace, L | 1 |
Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
Fernández-Cuenca, F; Martínez-Martínez, L; Pascual, A; Perea, EJ | 1 |
Petrini, B | 1 |
Alfarano, A; Gennari, F; Mignone, F; Romagnoli, R; Salizzoni, M; Scolfaro, C; Veltri, A | 1 |
Chu, N; Duan, H; Huang, H; Lu, Y; Nie, W | 1 |
Benwill, JL; Wallace, RJ | 1 |
Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
Kadiri, NP; Mannelli, VK; Nemakayala, DR; Rai, MP | 1 |
Dalcolmo, MP; Daley, CL; Eather, G; Gayoso, R; Hasegawa, N; Jhun, BW; Koh, WJ; Kwak, N; Namkoong, H; Park, J; Thomson, R; van Ingen, J; Yim, JJ; Zweijpfenning, SMH | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Kang, N; Kim, H; Koh, WJ; Kwon, OJ; Lee, NY | 1 |
Hakamifard, A; Naji Esfahani, SS; Shafiee, F; Soltani, R | 1 |
Bartolomeo, K; Hassanein, M; Vachharajani, TJ | 1 |
Boeree, MJ; Danho, R; Hoefsloot, W; Kuipers, S; Pennings, LJ; Schildkraut, JA; Svensson, EM; van Ingen, J; Wertheim, HFL; Zweijpfenning, SMH | 1 |
Kho, BG; Kim, TO; Kim, YI; Kwon, YS; Lee, JK; Lim, SC; Na, YO; Oh, HJ; Park, HK; Park, HY; Shin, HJ | 1 |
Güler, N; Süleyman, A; Tamay, Z | 1 |
Chhaya, N; Koo, EH; Miller, D; Shaik, N; Tonk, RS; Weiss, M; Zhu, A | 1 |
Aldridge, BB; Degefu, YN; Klickstein, J; Larkins-Ford, J; Leus, PA; Maurer, FP; Poonawala, H; Smith, TC; Stone, D; Thorpe, CM; Van, N | 1 |
Brown-Elliott, BA; Brunton, AE; Fuss, C; Griffith, DE; Philley, JV; Siegel, SAR; Strnad, L; Sullivan, PE; Wallace, RJ; Winthrop, KL | 1 |
5 review(s) available for amikacin and zithromax
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries | 2006 |
Mycobacterium abscessus: challenges in diagnosis and treatment.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Cystic Fibrosis; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Genotype; Humans; Molecular Diagnostic Techniques; Molecular Sequence Data; Mycobacterium Infections, Nontuberculous; Polymorphism, Single Nucleotide; Respiratory Tract Infections; Sequence Analysis, DNA; Transcription Factors; Treatment Outcome | 2014 |
Topics: Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Databases, Factual; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Management of peritoneal dialysis
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Humans; Linezolid; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis; Peritonitis | 2022 |
32 other study(ies) available for amikacin and zithromax
Article | Year |
---|---|
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Military Personnel; Minocycline; Polymyxin B; United States; Warfare | 2007 |
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Female; Hep G2 Cells; Humans; K562 Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship | 2017 |
A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide cultures.
Topics: Amikacin; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Erythromycin; Microbial Sensitivity Tests; Mycobacterium avium Complex | 1991 |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.
Topics: Amikacin; Azithromycin; Cells, Cultured; Drug Interactions; Erythromycin; Humans; Leucomycins; Macrophage Activation; Macrophages; Mycobacterium avium Complex; Tumor Necrosis Factor-alpha | 1988 |
Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.
Topics: Amikacin; Animals; Azithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophages; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recombinant Proteins | 1994 |
Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
Topics: Acquired Immunodeficiency Syndrome; Agar; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Fluoroimmunoassay; Humans; Microbial Sensitivity Tests; Mycobacterium avium; Nucleic Acid Hybridization; Rifabutin | 1997 |
Sensitization of Burkholderia cepacia to antibiotics by cationic drugs.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Burkholderia cepacia; Cations; Ceftazidime; Dibucaine; Diphenhydramine; Drug Therapy, Combination; Famotidine; Gentamicins; Lidocaine; Microbial Sensitivity Tests; Structure-Activity Relationship; Theobromine; Theophylline | 1998 |
Infectious crystalline keratopathy and endophthalmitis secondary to Mycobacterium abscessus in a monocular patient with Stevens-Johnson syndrome.
Topics: Adult; Amikacin; Anterior Chamber; Azithromycin; Corneal Diseases; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Keratoplasty, Penetrating; Male; Mycobacterium; Mycobacterium Infections; Stevens-Johnson Syndrome; Vision, Monocular | 1999 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Culture Media; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Propionibacterium acnes; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1999 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 2003 |
Possible donor-recipient bartonellosis transmission in a pediatric liver transplant.
Topics: Amikacin; Anti-Infective Agents; Antibodies, Bacterial; Azithromycin; Bartonella henselae; Cat-Scratch Disease; Child; Humans; Immunosuppressive Agents; Liver; Liver Neoplasms; Liver Transplantation; Lymph Nodes; Lymphomatoid Granulomatosis; Male; Postoperative Complications; RNA, Bacterial; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Tacrolimus; Tissue Donors; Transplants; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography | 2008 |
[The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Cefoxitin; Clarithromycin; Humans; Nontuberculous Mycobacteria; RNA, Ribosomal, 16S | 2014 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Azithromycin; Drug Resistance, Multiple, Bacterial; Hip Joint; Humans; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Tigecycline | 2018 |
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
Topics: Administration, Inhalation; Aged; Amikacin; Anti-Bacterial Agents; Azithromycin; Clofazimine; Drug Therapy, Combination; Female; Humans; Imipenem; Lung Diseases; Male; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Prospective Studies | 2021 |
In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Colistin; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.
Topics: Aged; Amikacin; Antitubercular Agents; Azithromycin; Biomarkers; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Stem Cells | 2022 |
Life-threatening Mycobacterium intracellulare pleuritis in an immunocompetent host: Case reports.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Ethambutol; Humans; Immunocompromised Host; Male; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pleurisy; Rifampin; Tomography, X-Ray Computed | 2021 |
Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Ceftazidime; Child; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Humans; Levofloxacin; Meropenem; Piperacillin; Retrospective Studies; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Outcomes of Nontuberculous Mycobacterial Keratitis After Clear Corneal Incision Phacoemulsification Surgery: A Case Series of 6 Eyes in South Florida.
Topics: Abscess; Amikacin; Azithromycin; Clarithromycin; Eye Infections, Bacterial; Florida; Humans; Keratitis; Mycobacterium Infections, Nontuberculous; Phacoemulsification | 2022 |
Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Drug Interactions; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |
Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Clofazimine; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Humans; Leprostatic Agents; Liposomes; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2023 |